CorWave Raises $17.1 Million in Series B Financing

CorWave, has announced that it has completed a $17.1 million (€15.5M) Series B financing.

Sanifit Announces Initiation of First Clinical Trial of SNF472 in Patients with Calciphylaxis

The recently initiated Phase II study is the first clinical investigation of SNF472 in patients with newly diagnosed calciphylaxis.

Ysios Capital raises €126,4 m ($140 m) for its second fund, Ysios Biofund II Innvierte

Ysios Capital has closed its second fund, Ysios BioFund II Innvierte, at €126,4 M exceeding its initial target fund size of €100 M.

CVRx® Names Tom Moore Vice President of U.S. Market Development

CVRx, Inc., a private medical device company, today announced the appointment of Tom Moore to the newly created, officer position of Vice President, U.S. Market Development.

STAT-Diagnostica Attracts Siemens Venture Capital as a New Investor

Aura Biosciences Secures $8 Million in Additional Funding and Augments Board of Directors and Clinical Advisory Board

The round of financing consisted of expanded funding commitments from its existing investors

TiGenix Appoints Dr. June Almenoff to its Board of Directors

TiGenix Business and Financial Update for the First Half 2016

Parkinson’s disease: Prexton Therapeutics completes phase 1 clinical trial

CVRx® Secures $113 Million in New Financing

CVRx, Inc., has secured equity financing totaling $93 million and a new $20 million debt facility.